C-reactive protein as a systemic marker of inflammation in periodontitis.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 21057970)

Published in Eur J Clin Microbiol Infect Dis on November 06, 2010

Authors

A Pejcic1, L J Kesic, J Milasin

Author Affiliations

1: Department of Periodontology and Oral Medicine, Medical Faculty, University of Nis, Nade Tomic 3/5, 18000, Nis, Serbia. dpejca@open.telekom.rs

Associated clinical trials:

Trial of Toothpaste to Reduce Plaque and Inflammation | NCT02666508

Articles cited by this

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23

Microbial complexes in subgingival plaque. J Clin Periodontol (1998) 15.90

Periodontal diseases. Lancet (2005) 10.13

Periodontal disease and cardiovascular disease. J Periodontol (1996) 5.78

Association between dental health and acute myocardial infarction. BMJ (1989) 3.94

Identification of periodontal pathogens in atheromatous plaques. J Periodontol (2000) 3.45

Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol (2000) 3.03

Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol (2001) 2.97

Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc (2001) 2.94

High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation (2006) 2.69

Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol (2000) 2.64

Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation (2005) 2.36

Systemic markers of inflammation in periodontitis. J Periodontol (2005) 2.31

Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol (1997) 2.30

Higher risk of preterm birth and low birth weight in women with periodontal disease. J Dent Res (2002) 2.25

Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J (2003) 2.09

Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med (2003) 2.06

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol (2006) 1.96

Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol (2003) 1.69

Relationship of destructive periodontal disease to the acute-phase response. J Periodontol (2003) 1.65

Relationship between periodontal disease and systemic health. Periodontol 2000 (2001) 1.55

Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk (1999) 1.51

Dental infections and coronary atherosclerosis. Atherosclerosis (1993) 1.39

Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J (1993) 1.36

The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord (2003) 1.30

Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J (2006) 1.22

Association between periodontal disease and acute myocardial infarction. J Periodontol (2000) 1.20

Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation. Infect Immun (1995) 1.16

Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol (2002) 1.11

Longitudinal stability of serum immunoglobulin G responses to periodontal bacteria. J Clin Periodontol (2004) 0.99

Total tooth loss and prevalent cardiovascular disease in men and women: possible roles of citrus fruit consumption, vitamin C, and inflammatory and thrombotic variables. J Clin Epidemiol (2003) 0.98

Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies. J Clin Microbiol (2002) 0.96

Periodontitis and plasma C-reactive protein during pregnancy. J Periodontol (2006) 0.94

C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J Clin Periodontol (2010) 0.92

Checkerboard assessments of serum antibodies to oral microbiota as surrogate markers of clinical periodontal status. J Clin Periodontol (2001) 0.91

Human gingiva is another site of C-reactive protein formation. J Clin Periodontol (2010) 0.91

Coronary heart disease and periodontitis -- a case control study in Chilean adults. J Clin Periodontol (2002) 0.89

Immune responses to heat shock protein in Porphyromonas gingivalis-infected periodontitis and atherosclerosis patients. J Periodontal Res (2003) 0.83

Neurohumoral and inflammatory activation in patients with coronary artery disease treated with statins. Heart (2006) 0.77

[Identification of periodontopathogen microorganisms by PCR technique]. Srp Arh Celok Lek (2008) 0.77

Articles by these authors

Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart (1997) 1.30

Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. Am J Hum Genet (1995) 1.09

Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families. Oncol Rep (1999) 0.98

Periodontal therapy improves gastric Helicobacter pylori eradication. J Dent Res (2009) 0.93

Molecular and biochemical characterizations of human oral lactobacilli as putative probiotic candidates. Oral Microbiol Immunol (2007) 0.89

Bcl-2 expression in oral squamous cell carcinoma. Ann N Y Acad Sci (2007) 0.88

Survivin expression in odontogenic keratocysts and correlation with cytomegalovirus infection. Oral Dis (2009) 0.84

Human cytomegalovirus is present in odontogenic cysts. Oral Microbiol Immunol (2007) 0.82

Tetraploidy in a 26-month-old girl (cytogenetic and molecular studies). Clin Genet (2002) 0.79

Genetic factors in dilated cardiomyopathy. Arch Mal Coeur Vaiss (1996) 0.79

Chronic gingivitis: the prevalence of periodontopathogens and therapy efficiency. Eur J Clin Microbiol Infect Dis (2012) 0.78

Prevalence of Y chromosome microdeletions in infertile men with severe oligozoospermia in Serbia. Genet Couns (2007) 0.78

High incidence of H-ras oncogene mutations in squamous cell carcinoma of lip vermilion. J Oral Pathol Med (1994) 0.76

Prognostic value of survivin expression in Wilms tumor. J BUON (2012) 0.76

Sex steroid receptors in transformed human cervical tissue. Eur J Gynaecol Oncol (1986) 0.75

Ring chromosomes in bladder cancer. Cancer Genet Cytogenet (1987) 0.75

[Changes in steroid receptors during histopathologic transformation of tissue in the human uterus]. Jugosl Ginekol Opstet (1985) 0.75

Chromosome analysis in patients with bladder tumor. Urol Int (1988) 0.75

[Significance of genetic-epidemiologic studies in research on disease etiology]. Vojnosanit Pregl (1998) 0.75

Steroid receptors in human uterine carcinoma. Their biological importance and therapeutic implications. Eur J Gynaecol Oncol (1985) 0.75

Molecular genetics of dilated cardiomyopathies. Eur Heart J (1995) 0.75

Presence of herpes simplex virus on the oral mucosa in patients undergoing chemotherapy. Scott Med J (2007) 0.75

Sister chromatid exchanges in patients with carcinoma in situ of cervix uteri. Cancer Genet Cytogenet (1992) 0.75